Literature DB >> 3312937

Low protein and low phosphorus diet in patients with chronic renal failure: influence on glucose tolerance and tissue insulin sensitivity.

H Gin1, M Aparicio, L Potaux, V de Precigout, J L Bouchet, J Aubertin.   

Abstract

Ten patients with advanced renal failure (glomerular filtration rate 25 mL/min) were treated with a low phosphorus and low protein diet supplemented with ketoacid analogues. Before starting the diet and four months afterwards, a 50 g oral glucose tolerance test with a three step euglycemic insulin clamp was carried out. A dose-response curve of total body insulin sensitivity was plotted. By the fourth month, glucose tolerance had improved with significantly lower T0, T30, and T60 insulin levels. These results are attributed to the improvement in insulin action as demonstrated by the clamp technique. The dose-response curve had a distinctly higher plateau after dietary treatment, and the tissue sensitivity index to insulin (M/l ratio) was significantly improved. It is suggested that treatment of uremic patients with a low protein diet may reduce levels of a putative insulin inhibitor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312937     DOI: 10.1016/0026-0495(87)90029-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Evaluation of long-term aggressive dietary management of chronic renal failure in children.

Authors:  K F Jureidini; R J Hogg; M J van Renen; T R Southwood; P H Henning; L Cobiac; L Daniels; S Harris
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

2.  Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.

Authors:  Ch Sampanis
Journal:  Hippokratia       Date:  2008-01       Impact factor: 0.471

3.  Infection in Advanced Chronic Kidney Disease and Subsequent Adverse Outcomes after Dialysis Initiation: A Nationwide Cohort Study.

Authors:  Chih-Hsiang Chang; Pei-Chun Fan; George Kuo; Yu-Sheng Lin; Tsung-Yu Tsai; Su-Wei Chang; Ya-Chung Tian; Cheng-Chia Lee
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.